Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-039-8 | CAS number: 25322-69-4 1 - 4.5 moles propoxylated
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Propane-1,2-diol, propoxylated was tested according to OECD Guideline 471 (Bacterial reverse mutation assay). There were negative findings both with and without metabolic activation.
The results from a mammalian point mutation assay have been 'read across' from 2, 2', 2''-nitrilotriethanol, propoxylated. They are negative.
The results of chromosome aberration assays have been 'read across' from 2,2',2''-nitrilotriethanol, propoxylated, glycerol, propoxylated (alpha, alpha', alpha''-1,2,3-propanetriyltris[w-hydroxypoly(oxy-(methyl-1,2-ethanediyl))]) and D-glucitol, propoxylated.
Short description of key information:
Three in vitro mutagenicity tests using different end points were all negative. Therefore further testing is not required.
In all three in vitro assays, one by direct test and two by 'read across,' as permitted by Annex XI para 1.5, one nominally from 2, 2', 2''-nitrilotriethanol, propoxylated and the other nominally from 2, 2', 2''-nitrilotriethanol, propoxylated, glycerol, propoxylated and D-glucitol, propoxylated (see report from Paul Illing Consultancy Services Ltd and Marlin Consultancy (Illing and Barratt,, 2007). The report identifies that 2, 2', 2''-nitrilotriethanol, propoxylated is the most bioavailable of the polyols linked by an ether group. Thus, it is inappropriate to undertake the tests on propane-1,2-diol, propoxylated. For further details concerning the groupings consult Illing and Barratt (2007).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Teh findings from in-vitro genotoxicity testing do not warrant classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
